Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 4, 2017
Role of hepatectomy in gastric cancer with multiple liver-limited metastasesHiromichi Shirasu, Takahiro Tsushima, Masahiro Kawahira, et al.
The Oncologist|June 7, 2023
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib StudyHiroya Taniguchi, Kentaro Yamazaki, Toshiki Masuishi, et al.
International Journal of Clinical Oncology|June 23, 2018
Phase II study of S-1 plus oxaliplatin 130 mg/m<sup>2</sup> in Japanese patients with advanced gastric cancerYosuke Kito, Nozomu Machida, Sadayuki Kawai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2010
[Peritoneal disseminated recurrence after total gastrectomy for perforated gastric malignant lymphoma--a case report]Yutaka Tanizawa, Masanori Terashima, Masanori Tokunaga, et al.
Molecular and Clinical Oncology|December 2, 2015
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatinYoshiki Horie, Kentaro Yamazaki, Taro Funakoshi, et al.
International Journal of Clinical Oncology|September 25, 2014
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastasesNaoki Izawa, Yusuke Onozawa, Tomomi Hikosaka, et al.
JAMA Oncology|October 15, 2020
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical TrialHidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, et al.
Oral Oncology|May 31, 2024
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trialYoshinori Imamura, Naomi Kiyota, Makoto Tahara, et al.
Cancer Medicine|September 30, 2024
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, et al.
Gastrointestinal Endoscopy|June 30, 2025
Optimal number of needle passes in EUS-guided tissue sampling for genomic profiling: a randomized, noncomparative trialHirotoshi Ishiwatari, Kazuma Ishikawa, Junya Sato, et al.
Pageof 11